CAMP4 Therapeutics Corp. (CAMP)
4.26
-0.07
(-1.62%)
USD |
NASDAQ |
Nov 11, 12:20
CAMP4 Therapeutics Profit Margin (Quarterly) : -1.52K% for Sept. 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -1.52K% |
| June 30, 2026 | -1.88K% |
| March 31, 2026 | -1.42K% |
| December 31, 2025 | -11.58K% |
| September 30, 2025 | -1.90K% |
| June 30, 2025 | -840.8% |
| March 31, 2025 | -1.45K% |
| Date | Value |
|---|---|
| December 31, 2024 | -2.04K% |
| September 30, 2024 | |
| June 30, 2024 | |
| March 31, 2024 | |
| December 31, 2023 | |
| September 30, 2023 | -3.34K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 15.64% |
| Alnylam Pharmaceuticals, Inc. | -- |
| Anika Therapeutics, Inc. | -1.02% |
| Savara, Inc. | -- |
| Vericel Corp. | 16.59% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -248.5% |
| Return on Assets | -112.7% |
| Return on Invested Capital | -230.3% |
| Gross Profit Margin (Quarterly) | 72.46% |
| Operating Margin (Quarterly) | -738.8% |
| Return on Net Operating Assets | -1.94K% |